Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants

Vaccine

Volumn 25, Issue 23, 2007, Pages 4575-4585

  Sokolovska, Anna ^a   Hem, Stanley L ^b   HogenEsch, Harm ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Adjuvants; Dendritic cells; T helper cell differentiation

Indexed keywords

ADJU PHOS; ADJUVANT; ALUMINUM DERIVATIVE; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; OVALBUMIN; REHYDRAGEL; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; ANTIGEN PRESENTATION; CASPASE 1; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PHOSPHATES; TH1 CELLS; TH2 CELLS;

EID: 34248400446     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.045     Document Type: Article

References (49)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
2. Cunningham A.J., and Lafferty K.J. A simple conservative explanation of the H-2 restriction of interactions between lymphocytes. Scand J Immunol 6 1-2 (1977) 1-6
3. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 (1996) 233-258
4. Kalinski P., Hilkens C.M., Wierenga E.A., and Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20 12 (1999) 561-567
5. Pape K.A., Khoruts A., Mondino A., and Jenkins M.K. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J Immunol 159 2 (1997) 591-598
6. H2 cells in vivo. J Immunol 167 8 (2001) 4345-4350
7. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8 3 (1996) 348-354
8. De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184 (1996) 1413-1424
9. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., and Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189 (1999) 821-829
10. Hem S.L., and White J.L. Structure and properties of aluminum-containing adjuvants. In: Powell M.F., and Newman M.J. (Eds). Vaccine design. The subunit and adjuvant approach vol. 9 (1995), Plenum Press, New York 249-276
11. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20 Suppl 3 (2002) S34-S39
12. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 22 27-28 (2004) 3658-3668
13. Brewer J.M. (How) do aluminium adjuvants work?. Immunol Lett 102 1 (2006) 10-15
14. Schijns V.E.J.C. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12 (2000) 456-463
15. Weissburg R.P., Berman P.W., Cleland J.L., Eastman D., Farina F., Frie S., et al. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm Res 12 (1995) 1439-1446
16. Iyer S., HogenEsch H., and Hem S.L. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine 21 11-12 (2003) 1219-1223
17. Romero-Mendez I., Shi Y., HogenEsch H., and Hem S.L. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25 (2007) 825-833
18. Ulmer J.B., DeWitt C.M., Chastain M., Friedman A., Donnelly J.J., McClements W.L., et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18 (2000) 18-28
19. Brewer J.M., Conacher M., Gaffney M., Douglas M., Bluethmann H., and Alexander J. Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of alum and Freund's adjuvant. Immunol 93 (1998) 41-48
20. Brewer J.M., Conacher M., Satoskar A., Bluethmann H., and Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 26 (1996) 2062-2066
21. H2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 163 (1999) 6448-6454
22. Pollock K.G., Conacher M., Wei X.Q., Alexander J., and Brewer J.M. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 108 2 (2003) 137-143
23. Ulanova M., Tarkowski A., Hahn-Zoric M., and Hanson L.A. The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun 69 2 (2001) 1151-1159
24. Sun H., Pollock K.G., and Brewer J.M. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21 9-10 (2003) 849-855
25. Rimaniol A.C., Gras G., Verdier F., Capel F., Grigoriev V.B., Porcheray F., et al. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 22 (2004) 3127-3135
26. Morefield G.L., Sokolovska A., Jiang D., HogenEsch H., Robinson J.P., and Hem S.L. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23 13 (2005) 1588-1595
27. Lutz M.B., Kukutsch N., Ogilvie A.L.J., Rössner S., Koch F., Romani N., et al. An advanced culture method for generating large quantitities of highly pure dendritic cells from mouse bone marrow. J Immunol Meth 223 (1999) 77-92
28. Shimonkevitz R., Kappler J., Marrack P., and Grey H. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 158 2 (1983) 303-316
29. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
30. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 4 (2001) 402-408
31. Watts T.H., Brian A.A., Kappler J.W., Marrack P., and McConnell H.M. Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci USA 81 23 (1984) 7564-7568
32. Burns K., Martinon F., and Tschopp J. New insights into the mechanism of IL-1beta maturation. Curr Opin Immunol 15 1 (2003) 26-30
33. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., and Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70 (1998) 281-312
34. Mannhalter J.W., Neychev H.O., Zlabinger G.J., Ahmad R., and Eibl M.M. Modulation of the human immune response by non-toxic and non-pyrogenic adjuvant aluminum hydroxide: effect on antigen uptake and antigen presentation. Clin Exp Immunol 61 (1985) 143-151
35. Morefield G.L., Jiang D., Romero-Mendez I.Z., Geahlen R.L., HogenEsch H., and Hem S.L. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23 12 (2005) 1502-1506
36. Ramage P., Cheneval D., Chvei M., Graff P., Hemmig R., Heng R., et al. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 270 (1995) 9378-9383
37. Wang S., Miura M., Jung Y.K., Zhu H., Li E., and Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92 4 (1998) 501-509
38. Matsue H., Cruz Jr. P.D., Bergstresser P.R., and Takashima A. Langerhans cells are the major source of mRNA for IL-1 beta and MIP-1 alpha among unstimulated mouse epidermal cells. J Invest Dermatol 99 5 (1992) 537-541
39. Jankovic D., Caspar P., Zweig M., Garcia-Moll M., Showalter S.D., Vogel F.R., et al. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J Immunol 159 (1997) 2409-2417
40. Sporri R., and Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6 2 (2005) 163-170
41. H2-mediated immunity. Eur J Immunol 34 12 (2004) 3674-3681
42. Hoshino T., Wiltrout R.H., and Young H.A. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 162 9 (1999) 5070-5077
43. Xu D., Trajkovic V., Hunter D., Leung B.P., Schulz K., Gracie J.A., et al. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol 30 (2000) 3147-3156
44. Kwissa M., Lindblad E.B., Schirmbeck R., and Reimann J. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response. J Mol Med 81 8 (2003) 502-510
45. Wilcock L.K., Francis J.N., and Durham S.R. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy 34 9 (2004) 1373-1378
46. Audran R., Cachat M., Lurati F., Soe S., Leroy O., Corradin G., et al. Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen. Infect Immun 73 (2005) 8017-8026
47. Kawakami K., Kinjo Y., Uezu K., Miyagi K., Kinjo T., Yara S., et al. Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18. Microbes Infect 6 (2004) 339-349
48. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175 (2005) 2191-2200
49. Shi Y., HogenEsch H., Regnier F., and Hem S.L. Detoxification of endotoxin by aluminum-containing adjuvants. Vaccine 19 (2000) 1747-1752